Status:
UNKNOWN
Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
Lead Sponsor:
Radboud University Medical Center
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Various methods of FDG-PET signal segmentation will be validated by correlation of histopathologically measured tumor dimensions in lymph node dissection specimens of head-and-neck cancer patients.
Eligibility Criteria
Inclusion
- All patients with N+ squamous cell carcinoma of the head and neck, planned for neck dissection.
- Age \>18 years.
Exclusion
- Pregnancy.
- Women breast feeding
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00782691
Start Date
July 1 2008
Last Update
October 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500HB